Q3 2025 Covestro AG Earnings Call Transcript
Key Points
- Covestro AG (CVVTF) completed the acquisition of Pontacol in Q3 2025 and signed another value-accretive transaction expected to close in Q1 2026, enhancing its global aliphatics production footprint.
- The recent acquisition is expected to add a low double-digit million euro EBITDA and synergies of up to high double-digit euro million amounts within the next five years.
- Covestro AG (CVVTF) achieved an EBITDA of EUR242 million, which is towards the upper end of their guidance range, due to successful cost-saving measures.
- The company reported a positive free operating cash flow of EUR111 million for Q3 2025.
- Covestro AG (CVVTF) remains committed to maintaining a solid investment-grade rating, confirmed by Moody's with a stable outlook.
- Sales volumes declined by 1.5% year over year, impacted by the Dormagen fire incident and challenging macroeconomic conditions.
- Q3 2025 sales declined by 12% to EUR3.2 billion, primarily due to negative pricing and adverse foreign exchange impacts.
- EBITDA decreased by 15.7% year over year to EUR242 million, affected by a negative pricing delta and adverse FX effects.
- The Dormagen incident had a significant operational impact, with an estimated burden of up to EUR150 million for FY 2025.
- Covestro AG (CVVTF) narrowed its FY 2025 EBITDA guidance to EUR700 million to EUR800 million, reflecting ongoing market challenges and the impact of the Dormagen incident.
Welcome to the Covestro earnings call on the third quarter results. The company is represented by Christian Baier, our CFO. (Event Instructions) You will find the quarterly statement and earnings call presentation on our IR website. I assume you have read the Safe Harbor statement.
With that, I would now like to turn the conference over to Christian.
Thank you, Ronald, and good afternoon, everybody. I would like to start my presentation with some insights into a recent acquisition. Following the successful completion of the purchase of Pontacol in Q3 2025, Covestro has signed another value-accretive transaction, which is expected to close in Q1 2026, depending on regulatory approvals. This deal will also benefit our Solutions & Specialties segment with the acquisition of two HDI derivative production facilities from Vencorex in Rayong, Thailand and Freeport in the US.
This strategic move enhances
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
